Allergan, Inc. (NYSE:AGN) today announced that it has completed its acquisition of Inamed Corporation (NASDAQ:IMDC). The acquisition of Inamed expands Allergan's global position as a premier specialty pharmaceutical and medical device company in high-growth markets and creates a world-leading medical aesthetics franchise, providing a broad, complementary portfolio of pharmaceutical and medical device products and offerings to physicians and patients.
